Fundraising FoxBiolog Inc /DE
Hayward, US · Founded 2022 · Delaware corporation
Find your way into Biolog Inc /DE
Sign up to see every warm intro you have to Biolog Inc /DE
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biolog Inc /DE team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RW
Robert WickeExecutiveRobert Wicke is an executive with over three decades of experience in technology and life sciences, including roles leading large-scale operations at companies in the instrumentation and software sectors. He has held executive and director positions at multiple organizations acquired for significant valuations, with expertise spanning opto-electrical-mechanical instruments, bioinformatics software, genomic analysis, and label-free detection technologies across biopharmaceutical, medical, and industrial markets.
JN
Jason NoviCFO
DW
David WeberNamed on SEC filing
JD
Joseph D. KeeganNamed on SEC filing
Board
TH
Tim HarknessBoard director
WS
William SniderBoard director
CS
Chad SouvignierBoard director
AR
Anne Rogove StoneBoard director
Reported raises · per SEC filings
Form D private placements$33.6M disclosed across 2 rounds · 2022–2025
▶$16.1MraisedFeb 2025 · 22 investors · BiotechnologyRule 506(b)
▶$16.1MraisedFeb 2025 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tim HarknessDirector
- William SniderDirector
- Robert WickeExecutive Officer, Director
- Chad SouvignierDirector
- Anne Rogove StoneDirector
- Offering amount
- $17.1M
- Amount sold
- $16.1M
- Minimum investment
- $1
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$17.5MraisedFeb 2023 · 20 investors · BiotechnologyRule 506(b)
▶$17.5MraisedFeb 2023 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tim HarknessDirector
- Jason NoviExecutive Officer
- Chad SouvignierDirector
- Robert WickeExecutive Officer, Director
- David WeberDirector
- Joseph D. KeeganDirector
- Bill SniderDirector
- Offering amount
- $17.5M
- Amount sold
- $17.5M
- Minimum investment
- $1
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Biolog Inc /DE raised?
- Biolog Inc /DE has disclosed $33.6M raised across 2 rounds.
- Where is Biolog Inc /DE headquartered?
- Biolog Inc /DE is headquartered in Hayward, US.